- AdventHealth Research Institute
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity. Most of what we know about this comes from animal studies or human observations, so there is still a lot to learn.
Our recent study, published in the American Journal of Clinical Nutrition, aimed to fill in some of these gaps. We looked at small molecules in the body—called metabolites—including those that are produced when food is digested by both our bodies and the microbes in our gut.
We studied healthy adults without obesity and fed them two different diets:
• A high-fiber diet (called the Microbiome Enhancer Diet or MBD), which was low in processed foods.
• A Western-style diet (WD), which was low in fiber and high in processed foods.
Both diets had the same number of calories and macronutrient percentages, and participants were carefully monitored to make sure they ate exactly what was provided.
Our study goals were:
1. To find chemical “fingerprints” of each diet that could be validated in future research.
2. To understand how diet and gut microbes work together to affect how much energy the body absorbs.
What we found:
1. The high-fiber diet changed many of the body’s metabolites compared to the processed diet. These changes could help identify diets that modulate how much energy is absorbed from the diet, in part by altering the gut microbiome.
2. Some of the changes in metabolites excreted in the stool were linked to less energy being absorbed and more growth of gut microbes—suggesting potential mechanisms by which the microbes might be using some of the energy themselves and preventing energy from being absorbed by the host.
3. Surprisingly, the high-fiber diet increased levels of a ketone body called beta-hydroxybutyrate, which usually rises during fasting or low-carb diets. This happened even though both diets had the same number of calories which were calculated to maintain participants’ starting body weight, hinting that an MBD might mimic some effects of fasting.
Why this matters:
These findings help us understand how diet and gut microbes work together to influence energy use in the body. This could lead to new ways to prevent or treat obesity by targeting the gut microbiome.
To read the full published article please click below.
Recent News
The Next Frontier: Preventing Type 1 Diabetes Before It Starts
Recent research led by AdventHealth’s Translational Research Institute and others reveals that Type 1 diabetes develops gradually and can now be detected early through blood tests, opening the door to...
Advancing Heart Care: A New Chapter with the BrioVAD Study
The AdventHealth Research team recently completed Core Training for the INNOVATE 2254936 Vidic trial, bringing this novel device to AdventHealth.
AdventHealth Launches NIH-Funded THRIVE Trial to Address Apathy in Late-Life Depression
AdventHealth Neuroscience Institute is launching THRIVE, a new NIH-funded clinical trial led by geriatric neuropsychologist and neuroscience researcher Lauren Oberlin, PhD.
AdventHealth Leads the Nation in STAR Trial Enrollment
AdventHealth Research Institute (AHRI) is proud to be the highest enrolling site in the United States for the STAR trial.
Can Exercise Turn Back the Clock on Your Brain? New Study Says Yes
What if hitting the gym could actually make your brain younger? A new study suggests it can. Our research group found that adults who committed to a year of moderate-to-vigorous aerobic exercise—like...
Dr. Kirk Erickson Featured on Fox 35 to Talk About the Connection Between Physical Activity and Brain Health
AdventHealth Research Institutes own Dr. Kirk Erickson was recently featured on Fox 35 to talk about the connection between physical activity and brain health.
Conform Trial: Major Milestone Achieved
On August 8, 2025, our team successfully completed the very first implant day for the Conform Clinical Trial, enrolling and treating our first three patients with the Conformal CLAAS System for Left...
Dr. Vipul Patel Performs the Longest Distance Telesurgery Ever Completed
In our latest Clinician’s View, Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach.
AdventHealth’s Dr. Stephanie Compton Featured in ACS Highlight on Diet and Cancer Treatment
We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society.
Back-to-School with Type 1 Diabetes
Starting school is exciting and for families managing T1D, a little planning can make all the difference.
New Study Enrolling: RISE - Treating Ulcerative Colitis
We are proud to announce the launch of the new RISE study.
New Study Enrolling: SOMMA - Muscle, Mobility, and Aging Research
The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.